In Search for Clarity: U.S. Court Decisions On Whether to Imply Follow -the-Fortunes and Follow-the-Settlements Principles Into Reinsurance Contracts
17 May 2023
Undoubtedly, reinsurance practitioners learn early on certain fundamental principles and customary practices that define reinsurance. For many, Robert W. Strain, Reinsurance (6th ed. 1997) was required reading to try to understand what reinsurance is and isn’t (such as, for example, “reassurance”). Small wonder: the Strain treatise’s essays were written by, edited, and reviewed by “a veritable WHO’s WHO in the reinsurance business,” and recommended by their peers, “whose know-ledge, experience, and judgment . . . was, for the most part, from a life’s work.” In other words, Strain captures the principles and customs of the industry as well as anyone.
This story was published in ARIAS U.S. Quarterly. To download the publication, click here.
Author(s)
Related Insights
21 October 2024
Events
Legal Overview of the BIOSECURE Act
Foley special counsel John Strom is speaking in the Association for Accessible Medicine’s GRx+Biosims 2024 conference in a panel titled “Legal Overview of the BIOSECURE Act” on October 21.
04 October 2024
Innovative Technology Insights
Decoding California’s Recent Flurry of AI Laws
Governor Newsom signed over 18 AI-related bills into law during September, impacting numerous industries.
17 October 2024
Events
Top Compliance Considerations when Commercializing in the U.S.
Kyle Faget and Nathan "Nate" Beaver, co-chair of Foley's Medical Device and Equipment Area of Focus within the firm's Health Care & Life Sciences Sector, invite you to join us for a webinar on the compliance considerations you need to know when you are commercializing your medical device products in the U.S.